Otsuka (OTCMKTS:OTSKY) Shares Gap Down – Here’s Why

Shares of Otsuka Holdings Co., Ltd. – Unsponsored ADR (OTCMKTS:OTSKY) gapped down before the market opened on Monday . The stock had previously closed at $34.27, but opened at $33.01. Otsuka shares last traded at $34.55, with a volume of 2,499 shares.

Analyst Upgrades and Downgrades

OTSKY has been the topic of several recent research reports. Zacks Research lowered Otsuka from a “hold” rating to a “strong sell” rating in a research report on Monday, March 2nd. Morgan Stanley upgraded Otsuka to an “overweight” rating in a research report on Friday, January 23rd. The Goldman Sachs Group cut shares of Otsuka from a “strong-buy” rating to a “strong sell” rating in a research report on Friday, February 27th. Finally, UBS Group raised shares of Otsuka to a “hold” rating in a research note on Tuesday, January 27th. One research analyst has rated the stock with a Buy rating, one has assigned a Hold rating and two have issued a Sell rating to the company. Based on data from MarketBeat.com, Otsuka has an average rating of “Reduce”.

Otsuka Stock Up 1.1%

The stock has a market capitalization of $37.23 billion and a P/E ratio of 15.07. The stock has a 50 day moving average price of $31.22 and a 200-day moving average price of $29.04. The company has a debt-to-equity ratio of 0.05, a current ratio of 2.17 and a quick ratio of 1.67.

About Otsuka

Otsuka Pharmaceutical Co, Ltd., trading in the U.S. under the ticker OTCMKTS:OTSKY, is a global healthcare company headquartered in Tokyo, Japan. The firm’s core activities span the development, manufacturing and marketing of prescription pharmaceuticals, consumer healthcare products and nutraceuticals. Otsuka focuses its research on areas such as neuroscience, cardiovascular and renal therapies, and oncology, aiming to bring innovative treatments to patients worldwide.

Founded in 1964 by Busaburo Otsuka as a subsidiary of the Otsuka Group, the company has grown into a diversified healthcare enterprise over more than five decades.